GV

Launched as Google Ventures in 2009, GV supports innovative founders moving the world forward.

[GV @GVteam]

@partiful @shreyamurthy Read the full story from @wired: https://t.co/nzRm16dn0M

[GV @GVteam]

People already love @partiful for bringing events to life. Now they can buy tickets there too.

Congrats to @shreyamurthy, Joy Tao, and the entire team on this exciting milestone! 🎟️

[shreya @shreyamurthy]

huge news: you can now sell tickets on partiful 🎟️

[GV @GVteam]

@SambaNovaAI Excited to see this partnership come to life. The future of AI infrastructure is being built today ⚡🚀

[David Krane @kraneland]

Last year was a great success... so we're back! @GVteam is co-hosting Humans in the Loop- featuring many of the most ambitious, creative early-stage companies in consumer AI. Join us on June 10th in SF! https://t.co/cQsUfwa2TE

[GV @GVteam]

Read more from GV Partner Luna Schmid on why we invested: https://t.co/8J5rOAZGqx

[GV @GVteam]

Hackers are getting better at stealing credentials. MokN is helping enterprises catch them earlier.

Excited to lead the team’s Series A as they scale their “Phish-Back” platform, which detects stolen credentials before attackers use them.

[GV @GVteam]

@JasonGrohowski @KJSidz Listen to the whole conversation: https://t.co/jP8xSM8O8H

[GV @GVteam]

AI is making it easier to build, but the consumer companies that stick will come from founders who understand people deeply.

On Venture Grounds with @JasonGrohowski, GV Partner @KJSidz shared thoughts on consumer AI today, adoption gaps, the benefits of constraints, and more.

[GV @GVteam]

Verve's origin story https://t.co/TlzFIDZiHd

[GV @GVteam]

Amazing progress from @skathire and the Verve team! Incubated in the GV Cambridge office, now part of @EliLillyandCo and well on their way to improving patients' lives

[Sek Kathiresan MD @skathire]

Nearly 20 years ago, researchers discovered something fascinating: some people are naturally protected from heart attacks because one of their PCSK9 genes is turned off, leading to low cholesterol from birth.

That observation sparked a simple but ambitious question: can we give that same protection to others?

Results from the Heart-2 Phase 1 trial released today show early clinical evidence that could open the door to new possibilities.

These are results in 35 people and we have a lot left to learn. But, the results could potentially mean an entirely different way of treating high cholesterol — one infusion, lifelong cholesterol lowering.

See the thinking behind this approach:
https://t.co/PMzFI2ip9D

[TechCrunch @TechCrunch]

Marketing operating system Nectar Social raises $30M Series A led by Menlo https://t.co/YMC9lFchlv

[Harvey @harvey]

Introducing Contract Intelligence.

Contract agents take first pass on inbound contracts, apply your playbooks, and generate redlines.

See how clauses and negotiated positions are trending across your business.

Escalate what needs legal judgment, while agents handle the rest.

[GV @GVteam]

@harvey Such a smart way to move legal workstreams faster. 💡 Bravo to the @harvey team!

[GV @GVteam]

@TechCrunch So proud of the team! 👏

[GV @GVteam]

@hughes_rhys Huge add for the GV portfolio 🚀 Big shoutout to @thulme for bringing this one home!

[GV @GVteam]

@kyeshwant @BioVentureVoiCe Watch the full episode: https://t.co/avQuhDb3cn

[GV @GVteam]

Before co-leading GV’s life science investment team, @kyeshwant was a computer science student walking into startups during the rise of Google.
On @BioVentureVoice, he shares how medicine, entrepreneurship, and his father’s healthcare journey shaped his investing perspective.

[GV @GVteam]

@CNBC @tryramp @SierraPlatform @Ripple @harvey @EvidenceOpen Read the full list here: https://t.co/vIJds1prpY

[GV @GVteam]

Today's leading companies are built with AI at the core.

5 GV portfolio companies were named to @CNBC’s 2026 Disruptor 50, reflecting how quickly AI is becoming foundational across industries:

🗂️ @tryramp
💬 @sierraplatform
💵 @ripple
🧑‍⚖️ @harvey
🩺 @evidenceopen